• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Pharm . Comparative Study of Acetalated-Dextran Microparticle Fabrication Methods for a Clinically Translatable Subunit-based Influenza Vaccin

tetano

Editor, Senior Moderator
Int J Pharm


. 2024 Jan 22:123836.
doi: 10.1016/j.ijpharm.2024.123836. Online ahead of print. Comparative Study of Acetalated-Dextran Microparticle Fabrication Methods for a Clinically Translatable Subunit-based Influenza Vaccine

Erik S Pena[SUP] 1 [/SUP], Cole J Batty[SUP] 2 [/SUP], Dylan A Hendy[SUP] 2 [/SUP], Shuangshuang Yang[SUP] 3 [/SUP], Luis Ontiveros-Padilla[SUP] 2 [/SUP], Rebeca T Stiepel[SUP] 2 [/SUP], Jenny P-Y Ting[SUP] 3 [/SUP], Kristy M Ainslie[SUP] 4 [/SUP], Eric M Bachelder[SUP] 2 [/SUP]



Affiliations
Abstract

The most common influenza vaccines are inactivated viruses produced in chicken eggs, which is a time-consuming production method with variable efficacy due to mismatches of the vaccine strains to the dominant circulating strains. Subunit-based vaccines provide faster production times in comparison to the traditional egg-produced vaccines but often require the use of an adjuvant to elicit a highly protective immune response. However, the current FDA approved adjuvant for influenza vaccines (MF59) elicits a primarily helper T-cell type 2 (Th2)-biased humoral immune response. Adjuvants that can stimulate a Th1 cellular response are correlated to have more robust protection against influenza. The cyclic dinucleotide cGAMP has been shown to provide a potent Th1 response but requires the use of a delivery vehicle to best initiate its signalling pathway in the cytosol. Herein, acetalated dextran (Ace-DEX) was used as the polymer to fabricate microparticles (MPs) via double-emulsion, electrospray, and spray drying methods to encapsulate cGAMP. This study compared each fabrication method's ability to encapsulate and retain the hydrophilic adjuvant cGAMP. We compared their therapeutic efficacy to Addavax, an MF59-like adjuvant, and cGAMP Ace-DEX MPs provided a stronger Th1 response in vaccinated BALB/c mice. Furthermore, we compared Ace-DEX MPs to spray dried MPs composed from a commonly used polymer for drug delivery, poly(lactic-co-glycolic acid) (PLGA). We observed that all Ace-DEX MPs elicited similar humoral and cellular responses to the PLGA MPs. Overall, the results shown here indicate Ace-DEX can perform similarly to PLGA as a polymer for drug delivery and that spray drying can provide an efficient way to produce MPs to encapsulate cGAMP and stimulate the immune system.

Keywords: Drug Delivery System; Electrospray; Emulsion; Polymeric Particles; Spray Dry.

 
Back
Top Bottom